rs3840006

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_022489.4(INF2):​c.2310+8delA variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.59 ( 27179 hom., cov: 0)
Exomes 𝑓: 0.56 ( 234135 hom. )

Consequence

INF2
NM_022489.4 splice_region, intron

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.665

Publications

7 publications found
Variant links:
Genes affected
INF2 (HGNC:23791): (inverted formin 2) This gene represents a member of the formin family of proteins. It is considered a diaphanous formin due to the presence of a diaphanous inhibitory domain located at the N-terminus of the encoded protein. Studies of a similar mouse protein indicate that the protein encoded by this locus may function in polymerization and depolymerization of actin filaments. Mutations at this locus have been associated with focal segmental glomerulosclerosis 5.[provided by RefSeq, Aug 2010]
INF2 Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease dominant intermediate E
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet
  • focal segmental glomerulosclerosis 5
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • familial idiopathic steroid-resistant nephrotic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 14-104711014-CA-C is Benign according to our data. Variant chr14-104711014-CA-C is described in ClinVar as Benign. ClinVar VariationId is 261606.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.893 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
INF2NM_022489.4 linkc.2310+8delA splice_region_variant, intron_variant Intron 14 of 22 ENST00000392634.9 NP_071934.3 Q27J81-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
INF2ENST00000392634.9 linkc.2310+8delA splice_region_variant, intron_variant Intron 14 of 22 5 NM_022489.4 ENSP00000376410.4 Q27J81-1

Frequencies

GnomAD3 genomes
AF:
0.593
AC:
90046
AN:
151950
Hom.:
27158
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.641
Gnomad AMI
AF:
0.531
Gnomad AMR
AF:
0.653
Gnomad ASJ
AF:
0.565
Gnomad EAS
AF:
0.914
Gnomad SAS
AF:
0.627
Gnomad FIN
AF:
0.537
Gnomad MID
AF:
0.611
Gnomad NFE
AF:
0.532
Gnomad OTH
AF:
0.620
GnomAD2 exomes
AF:
0.607
AC:
148676
AN:
244882
AF XY:
0.599
show subpopulations
Gnomad AFR exome
AF:
0.640
Gnomad AMR exome
AF:
0.704
Gnomad ASJ exome
AF:
0.570
Gnomad EAS exome
AF:
0.920
Gnomad FIN exome
AF:
0.525
Gnomad NFE exome
AF:
0.540
Gnomad OTH exome
AF:
0.583
GnomAD4 exome
AF:
0.562
AC:
819702
AN:
1459118
Hom.:
234135
Cov.:
0
AF XY:
0.562
AC XY:
407783
AN XY:
725784
show subpopulations
African (AFR)
AF:
0.639
AC:
21382
AN:
33440
American (AMR)
AF:
0.695
AC:
30997
AN:
44594
Ashkenazi Jewish (ASJ)
AF:
0.572
AC:
14942
AN:
26118
East Asian (EAS)
AF:
0.908
AC:
35967
AN:
39616
South Asian (SAS)
AF:
0.616
AC:
53065
AN:
86156
European-Finnish (FIN)
AF:
0.529
AC:
27515
AN:
52022
Middle Eastern (MID)
AF:
0.589
AC:
3392
AN:
5762
European-Non Finnish (NFE)
AF:
0.538
AC:
597699
AN:
1111106
Other (OTH)
AF:
0.576
AC:
34743
AN:
60304
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
18428
36855
55283
73710
92138
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17192
34384
51576
68768
85960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.593
AC:
90110
AN:
152068
Hom.:
27179
Cov.:
0
AF XY:
0.597
AC XY:
44337
AN XY:
74324
show subpopulations
African (AFR)
AF:
0.641
AC:
26587
AN:
41458
American (AMR)
AF:
0.653
AC:
9989
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.565
AC:
1961
AN:
3468
East Asian (EAS)
AF:
0.914
AC:
4725
AN:
5168
South Asian (SAS)
AF:
0.625
AC:
3018
AN:
4830
European-Finnish (FIN)
AF:
0.537
AC:
5687
AN:
10588
Middle Eastern (MID)
AF:
0.622
AC:
183
AN:
294
European-Non Finnish (NFE)
AF:
0.532
AC:
36168
AN:
67950
Other (OTH)
AF:
0.621
AC:
1310
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1878
3757
5635
7514
9392
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
750
1500
2250
3000
3750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.440
Hom.:
2216
Bravo
AF:
0.606
Asia WGS
AF:
0.779
AC:
2705
AN:
3478
EpiCase
AF:
0.531
EpiControl
AF:
0.540

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 18, 2021
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 15, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 90% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 84. Only high quality variants are reported. -

Focal segmental glomerulosclerosis 5;C4302667:Charcot-Marie-Tooth disease dominant intermediate E Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Charcot-Marie-Tooth disease dominant intermediate E Benign:1
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Jun 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Focal segmental glomerulosclerosis Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.67
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3840006; hg19: chr14-105177351; COSMIC: COSV53031816; COSMIC: COSV53031816; API